These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14066040)

  • 1. TOXOPLASMIC RETINOCHOROIDITIS: A DOUBLE BLIND THERAPEUTIC STUDY.
    ACERS TE
    Arch Ophthalmol; 1964 Jan; 71():58-62. PubMed ID: 14066040
    [No Abstract]   [Full Text] [Related]  

  • 2. THERAPY OF TOXOPLASMIC RETINOCHOROIDITIS.
    O'CONNOR GR; REMINGTON JS
    Arch Ophthalmol; 1964 Jun; 71():883-5. PubMed ID: 14133880
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis].
    Psilas K; Petroutsos G; Aspiotis M
    J Fr Ophtalmol; 1990; 13(11-12):551-3. PubMed ID: 2081846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THERAPY OF TOXOPLASMOSIS UVEITIS.
    GHOSH M; LEVY PM; LEOPOLD IH
    Am J Ophthalmol; 1965 Jan; 59():55-61. PubMed ID: 14259942
    [No Abstract]   [Full Text] [Related]  

  • 5. [TOXOPLASMOSIS IN CHILE. RECENT STATE OF CLINICAL AND EPIDEMIOLOGICAL STUDIES].
    NIEDMANN G; THIERMANN E; NEGHME A
    Bol Chil Parasitol; 1963; 18():86-92. PubMed ID: 14109055
    [No Abstract]   [Full Text] [Related]  

  • 6. EXPERIMENTAL USE OF FOLINIC ACID IN THE TREATMENT OF TOXOPLASMOSIS WITH PYRIMETHAMINE.
    GILES CL; JACOBS L; MELTON ML
    Arch Ophthalmol; 1964 Jul; 72():82-5. PubMed ID: 14149756
    [No Abstract]   [Full Text] [Related]  

  • 7. [Toxoplasmic retinochoroiditis].
    Zhang MH; Yang HZ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1992; 10(3):215-8. PubMed ID: 1307280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photocoagulation of active toxoplasmic retinochoroiditis.
    Ghartey KN; Brockhurst RJ
    Am J Ophthalmol; 1980 Jun; 89(6):858-64. PubMed ID: 6966892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?
    Peacock JE; Greven CM; Cruz JM; Hurd DD
    Bone Marrow Transplant; 1995 Jun; 15(6):983-7. PubMed ID: 7581102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up.
    Fernandes Felix JP; Cavalcanti Lira RP; Cosimo AB; Cardeal da Costa RL; Nascimento MA; Leite Arieta CE
    Am J Ophthalmol; 2016 Oct; 170():176-182. PubMed ID: 27521607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired toxoplasmic chorioretinitis.
    Saari M; Vuorre I; Neiminen H; Räisänen S
    Arch Ophthalmol; 1976 Sep; 94(9):1485-8. PubMed ID: 786226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HEMATOLOGICAL SIDE-EFFECTS OF PYRIMETHAMINE IN THE TREATMENT OF OCULAR TOXOPLASMOSIS.
    TENPAS A; ABRAHAM JP
    Am J Med Sci; 1965 Apr; 249():448-53. PubMed ID: 14278655
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased serum levels of CXCL8 chemokine in acute toxoplasmic retinochoroiditis.
    Gonçalves RM; Rodrigues DH; Camargos da Costa AM; Teixeira MM; Ribeiro Campos W; Oréfice F; Teixeira AL
    Acta Ophthalmol Scand; 2007 Dec; 85(8):871-6. PubMed ID: 17488320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE RELATION BETWEEN TOXOPLASMOSIS AND FOCAL EXUDATIVE RETINOCHOROIDITIS.
    VAN METRE TE; KNOX DL; MAUMENEE AE
    Trans Am Acad Ophthalmol Otolaryngol; 1964; 68():810-29. PubMed ID: 14211238
    [No Abstract]   [Full Text] [Related]  

  • 15. Variations in recurrent active toxoplasmic retinochoroiditis.
    Friedmann CT; Knox DL
    Arch Ophthalmol; 1969 Apr; 81(4):481-93. PubMed ID: 5777756
    [No Abstract]   [Full Text] [Related]  

  • 16. DARAPRIM: A FOLIC ACID ANTAGONIST: THE DETECTION OF EARLY TOXICITY.
    MCGOWAN JP; LUPOVITCH A; KATASE RY
    Am J Ophthalmol; 1964 Oct; 58():608-11. PubMed ID: 14218394
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment].
    Timsit JC; Bloch-Michel E
    J Fr Ophtalmol; 1987; 10(1):15-23. PubMed ID: 3598056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis.
    Adán A; Mateo C; Wolley-Dod C
    Am J Ophthalmol; 2003 Mar; 135(3):386-7. PubMed ID: 12614761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular toxoplasmosis treatment and clinical monitoring of the patient.
    Terry JE; Young DD
    J Am Optom Assoc; 1982 Jul; 53(7):535-40. PubMed ID: 6896884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of active toxoplasmic retino-choroiditis.
    Nolan J; Rosen ES
    Br J Ophthalmol; 1968 May; 52(5):396-9. PubMed ID: 5301644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.